A groundbreaking study from Oklahoma State University highlights how neuroblastoma cells manage to dodge the immune system’s defenses. The research pinpoints a crucial protein, RD3, that plays a key role in controlling how these tumor cells behave and interact with immune responses. When RD3 is lost, neuroblastoma cells adapt, becoming harder to eliminate through treatments.
Read more at Times of India
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.